Synapsell Clinical Intelligence
Can we predict severe immune checkpoint inhibitor toxicity before it happens?
A Clinical Intelligence analysis of the scientific and clinical landscape around severe immune checkpoint inhibitor toxicity, with particular focus on myocarditis, myositis, early detection, risk stratification, and the investigators working on these problems.
Clinical Intelligence
From a clinical question to the scientific community around it
Synapsell Clinical Intelligence maps clinical concepts to emerging scientific communities, supporting evidence, clinical trials, and relevant investigators. The analysis can be progressively refined and reconfigured as new questions emerge.
Explore Clinical Intelligence